LOS ANGELES, Dec. 1, 2016 /PRNewswire/ -- ThermoLife International, LLC announced today that the United States Patent andTrademark Office (USPTO) has issued Notices of Intent to Issue Ex Parte Reexamination Certificates for ten (10) of ThermoLife's patents, which include over 350 claims (including 182 new claims) pertaining to amino acid/nitrates and their compounds,
The Patent Office's recognition of the patentability of ThermoLife's patent claims will allow ThermoLife to continue its patent enforcement actions, including those that have been stayed as a result of reexaminations. As stated by ThermoLife's owner, Ron Kramer, "ThermoLife consistently has believed that its patents were valid all along, and the outcome of the reexamination proceedings has now underscored this."
ThermoLife will now be vigorously enforcing its intellectual property rights through litigation against any company that sells infringing products without a license. Although always willing to reach a fair resolution, ThermoLife will not tolerate infringement of its patents. Accordingly, ThermoLife's legal team will be contacting the manufacturers, distributors, and retailers of infringing products and taking any necessary actions to protect its rights.
The patents with respect to which the USPTO has issued Notices of Intent to Issue Ex Parte Reexamination Certificates, as of December 1, 2016, are as follows:
8466187, 8952046, 8183288, 8178572, 8455531, 8034836, 8569368, 8952047, 8952045, 8569369
Companies wishing to inquire about licensing opportunities, or any manufacturers, distributors and retailers who would like to confirm whether a particular nitrate-containing product has a license from ThermoLife, should contact Ron Kramer of ThermoLife, at firstname.lastname@example.org.
ABOUT THERMOLIFE: Founded in 1998, ThermoLife is dedicated to developing real products that work. ThermoLife is a leading manufacturer in the sports nutrition and supplement industry. For more information about ThermoLife and its patents, please contact Ron Kramer of ThermoLife, at email@example.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/uspto-confirms-patentability-of-over-350-amino-acidnitrate-claims-in-10-of-thermolife-internationals-patents-300371916.html
SOURCE ThermoLife International, LLC
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All